Malegra, a brand of sildenafil citrate, is primarily formulated and approved for treating erectile dysfunction (ED) in men. It is not intended for use by women, children, or adolescents. Medical guidelines and product information consistently state that Malegra is not recommended for female patients .
Although sildenafil (the active ingredient in Malegra) has been studied for potential use in women, particularly for conditions like female sexual arousal disorder (FSAD), its effectiveness remains inconclusive. Some studies suggest it may increase blood flow to the genital area, potentially enhancing sensitivity and arousal. However, results have been mixed, and the U.S. Food and Drug Administration (FDA) has not approved sildenafil for use in women .
For women experiencing sexual dysfunction, FDA-approved treatments include flibanserin (Addyi) and bremelanotide (Vyleesi), which target different mechanisms than sildenafil and have shown more consistent efficacy .
